IP rights are not bottlenecks to vaccine production: Pharma companies Reuters Mar 10, 2021 The bottlenecks are the capacity, the scarcity of raw materials, scarcity of ingredients, and it is about the know-how, state…
Global Biopharmaceutical Industry pulling out all the stops to address Coronavirus public health… EP News Bureau Mar 24, 2020 The commitments demonstrate the combined will of leading companies in the field to share scientific expertise, technical skills…
